Artiva Biotherapeutics (ARTV)

Profile

Full Name

Artiva Biotherapeutics, Inc.

Ticker Symbol

ARTV

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

Indexes

Not included

Website

http://www.artivabio.com

Employees

89

Key Details

Price

$2.47(+0.82%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$251.00K(-99.25% YoY)

Annual EPS

-$5.81(-388.40% YoY)

PE ratio

-

Next earnings date

May 30, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$2.47
ARTV price is $2.47

30-Day Relative Volume

0.47
ARTV 30-day relative volume is 0.47

Price Performance

Price Most recent change

+0.82%
ARTV price was up +0.82% on Apr 25, 2025

Price YTD change

-75.5%
ARTV price is down -75.5% since January 1st

Price 1-year change

-
ARTV price 1-year change is unknown

Price 3-year change

-
ARTV price 3-year change is unknown

Price Range

Price All-time high

$17.31
ARTV price is currently -85.73% below its historical high of $17.31

Price 3-year low

$1.78
ARTV price is currently +38.76% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$60.18M
ARTV market capitalization is $60.18 million

Market cap 3-year change

-
ARTV market capitalization 3-year change is unknown

Market cap All-time high

$384.46M
ARTV market capitalization is currently -84.35% below its historical high of $384.46 million

Market cap sector rank

38.86%
ARTV market capitalization is higher than 38.86% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+4.65%
ARTV shares outstanding is up +4.65% year-on-year

Shares Outstanding 3-Year Change

-
ARTV shares outstanding 3-year change is unknown

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.08
ARTV beta is 1.08

200-day SMA

$8.95
ARTV price is currently -72.39% below its 200-day simple moving average

50-day SMA

$3.65
ARTV price is currently -32.40% below its 50-day simple moving average

RSI

42.12
ARTV 14-day relative strength index is 42.12

Volume

0.47
ARTV 30-day relative volume is 0.47

ATR

$0.34
ARTV average true range is $0.34

10-day Historical Volatility

108.59%
ARTV 10-day historical volatility is 108.59%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$251.00K
ARTV annual revenue is $251.00 thousand

Revenue Analysts estimate

-
ARTV annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-99.25%
ARTV annual revenue is down -99.25% year-on-year

Revenue Sector rank

7.74%
ARTV annual revenue is higher than 7.74% of companies in Healthcare sector

EPS

EPS

-$5.81
ARTV annual earnings per share is -$5.81

EPS Analysts estimate

-$2.54
ARTV annual earnings per share is currently +128.74% higher than the consensus analysts' forecast

EPS 1-year change

-388.4%
ARTV annual earnings per share is down -388.4% year-on-year

EPS Sector rank

17.03%
ARTV annual earnings per share is higher than 17.03% of companies in Healthcare sector

Profit

Gross profit

-
ARTV annual gross profit value is unknown

Gross margin

-
ARTV annual gross profit margin value is unknown

Operating profit

-$67.28M
ARTV annual operating income is -$67.28 million

Operating margin

-26.81K%
ARTV annual operating profit margin is -26.81 thousand%

Net income

-$58.49M
ARTV annual net profit is -$58.49 million

Net margin

-23.30K%
ARTV annual net profit margin is -23.30 thousand%

Expenses

Total expenses

$67.53M
ARTV annual total expenses is $67.53 million

Operating expenses

$67.53M
ARTV annual total operating expenses is $67.53 million

Cost of goods sold

-
ARTV annual cost of goods sold value is unknown

Selling, general & administrative expenses

$17.20M
ARTV annual SGA is $17.20 million

Depreciation and amortization

$2.43M
ARTV annual depreciation & amortization is $2.43 million

Interest expense

-
ARTV annual interest expense value is unknown

Income tax

$0.00
ARTV annual income tax is $0.00

EBIT & EBITDA

EBIT

-$67.28M
ARTV annual earnings before interest & taxes is -$67.28 million

EBITDA

-$64.85M
ARTV annual EBITDA is -$64.85 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$209.58M
ARTV annual total assets is $209.58 million

Non current assets

$20.95M
ARTV annual long term assets is $20.95 million

Current assets

$188.63M
ARTV annual total current assets is $188.63 million

Cash and cash equivalents

$40.23M
ARTV annual cash & cash equivalents is $40.23 million

Accounts receivable

$0.00
ARTV annual accounts receivable is $0.00

Inventory

-
ARTV annual inventory value is unknown

Liabilities

Total liabilities

$22.94M
ARTV annual total liabilities is $22.94 million

Long term liabilities

$10.69M
ARTV annual total long term liabilities is $10.69 million

Current liabilities

$12.25M
ARTV annual total current liabilities is $12.25 million

Accounts payable

$1.12M
ARTV annual accounts payable is $1.12 million

Debt

Total debt

$14.35M
ARTV annual total debt is $14.35 million

Total debt 1-year change

-15.13%
ARTV annual total debt is down -15.13% year-on-year

Long term debt

$10.61M
ARTV annual long term debt is $10.61 million

Short term debt

$3.74M
ARTV annual short term debt is $3.74 million

Equity & Capital

Shareholders equity

$186.64M
ARTV annual stockholders equity is $186.64 million

Book value

$186.64M
ARTV annual book value is $186.64 million

Retained earnings

-$246.68M
ARTV annual retained earnings is -$246.68 million

Working capital

$176.38M
ARTV annual working capital is $176.38 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$55.03M
ARTV annual cash flow from operations is -$55.03 million

Cash from operations 1-year change

-16.03%
ARTV annual cash flow from operations is down -16.03% year-on-year

Cash from investing

-$120.46M
ARTV annual cash flow from investing activities is -$120.46 million

Cash from investing 1-year change

-363.77%
ARTV annual cash flow from investing activities is down -363.77% year-on-year

Cash from financing

$162.23M
ARTV annual cash flow from financing activities is $162.23 million

Cash from financing 1-year change

+565.11%
ARTV annual cash flow from financing activities is up +565.11% year-on-year

CAPEX

CAPEX

$642.00K
ARTV annual capital expenditures is $642.00 thousand

CAPEX 1-year change

-80.29%
ARTV annual capital expenditures is down -80.29% year-on-year

Free Cash Flow

Free cash flow

-$55.67M
ARTV annual free cash flow is -$55.67 million

Free cash flow 1-year change

-9.84%
ARTV annual free cash flow is down -9.84% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ARTV annual gross profit margin value is unknown

Operating margin

-26.81K%
ARTV annual operating profit margin is -26.81 thousand%

Net margin

-23.30K%
ARTV annual net profit margin is -23.30 thousand%

ROA & ROE

ROA

-37.17%
ARTV annual return on assets is -37.17%

ROE

-475.05%
ARTV annual return on equity is -475.05%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ARTV price to earnings ratio value is unknown

PE ratio Sector rank

-
ARTV price to earnings ratio is unknown

PB Ratio

PB ratio

0.32
ARTV price to book ratio is 0.32

PB ratio Sector rank

22.59%
ARTV price to book ratio is higher than 22.59% of companies in Healthcare sector

PS Ratio

PS ratio

-
ARTV price to sales ratio value is unknown

PS ratio Sector rank

-
ARTV price to sales ratio is unknown

Enterprise value

Enterprise value

$34.30M
ARTV enterprise value is $34.30 million

Enterprise value Sector rank

35.36%
ARTV enterprise value is higher than 35.36% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-0.53
ARTV EV/EBITDA is -0.53

EV/EBITDA Sector rank

52.24%
ARTV EV/EBITDA is higher than 52.24% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

15.39
ARTV annual current ratio is 15.39

Quick ratio

-
ARTV annual quick ratio value is unknown

Leverage

Debt to equity

0.00
ARTV annual debt to equity ratio is 0.00

Interest coverage ratio

-
ARTV annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ARTV piotroski f-score value is unknown

Altman Z-Score

-0.12
ARTV altman z-score is -0.12

Analyst ratings

Recent major analysts updates

Apr 8, 25 Needham
Buy
Mar 26, 25 HC Wainwright & Co.
Buy
Mar 25, 25 Wedbush
Outperform
Mar 25, 25 Needham
Buy
Mar 25, 25 Cantor Fitzgerald
Overweight
Dec 30, 24 HC Wainwright & Co.
Buy
Nov 13, 24 Needham
Buy
Aug 30, 24 Needham
Buy
Aug 13, 24 Wedbush
Outperform
Aug 13, 24 TD Cowen
Buy

Institutional Ownership

Similar stocks

ADVM logo
Adverum Biotechnologies (ADVM)
ACHL logo
Achilles Therapeutics (ACHL)
ASRT logo
Assertio Holdings (ASRT)
PRE logo
Prenetics Global Limited (PRE)
Renovaro Biosciences (RENB)
MAIA logo
MAIA Biotechnology (MAIA)
NTRB logo
Nutriband (NTRB)
HYPR logo
Hyperfine (HYPR)
FORA logo
Forian (FORA)
  • What is the ticker symbol for Artiva Biotherapeutics?
  • Does Artiva Biotherapeutics pay dividends?
  • What sector is Artiva Biotherapeutics in?
  • What industry is Artiva Biotherapeutics in?
  • What country is Artiva Biotherapeutics based in?
  • Is Artiva Biotherapeutics in the S&P 500?
  • Is Artiva Biotherapeutics in the NASDAQ 100?
  • Is Artiva Biotherapeutics in the Dow Jones?
  • When was Artiva Biotherapeutics's last earnings report?
  • When does Artiva Biotherapeutics report earnings?
  • Should I buy Artiva Biotherapeutics stock now?

What is the ticker symbol for Artiva Biotherapeutics?

The ticker symbol for Artiva Biotherapeutics is NASDAQ:ARTV

Does Artiva Biotherapeutics pay dividends?

No, Artiva Biotherapeutics does not pay dividends

What sector is Artiva Biotherapeutics in?

Artiva Biotherapeutics is in the Healthcare sector

What industry is Artiva Biotherapeutics in?

Artiva Biotherapeutics is in the Biotechnology industry

What country is Artiva Biotherapeutics based in?

Artiva Biotherapeutics is headquartered in United States

Is Artiva Biotherapeutics in the S&P 500?

No, Artiva Biotherapeutics is not included in the S&P 500 index

Is Artiva Biotherapeutics in the NASDAQ 100?

No, Artiva Biotherapeutics is not included in the NASDAQ 100 index

Is Artiva Biotherapeutics in the Dow Jones?

No, Artiva Biotherapeutics is not included in the Dow Jones index

When was Artiva Biotherapeutics's last earnings report?

Artiva Biotherapeutics's most recent earnings report was on Mar 24, 2025

When does Artiva Biotherapeutics report earnings?

The next expected earnings date for Artiva Biotherapeutics is May 30, 2025

Should I buy Artiva Biotherapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page